CTS implements Ortho VIP Viral Marker Testing Platform

25Jan

CTS implements Ortho VIP Viral Marker Testing Platform

25 Jan, 2021 | Return|

On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the Prism to the VIP is one of the most significant changes we have made in the past three years. We implemented the new system through the dedication and extraordinary effort of everyone across the enterprise. Congratulations on this important success!

Reminder-Check flights and cargo hours for the Labor Day Holiday

O'Dina Hurlburt | 0 Comments

As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...

Confirmatory Algorithm and Assay Changes Effective September 30, 2019

O'Dina Hurlburt | 0 Comments

On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...

IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization

SuperUser Account | 0 Comments

IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization

COVID-19 Antibody Testing Frequently Asked Questions

Lindsey Houghton | 0 Comments

The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...

CTS exhibiting at AABB in San Antonio this weekend!

Lindsey Houghton | 0 Comments

As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...

CTS Implements HLA Class I and II Testing on the Gemini

Lindsey Houghton | 0 Comments

CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...

Articles